Pharmacokinetics, Efficacy, and Safety of Perampanel Oral Suspension on Seizure Frequency in Pediatric Subjects Maintained on One to Three Stable Antiepileptic Drugs

Completed · Phase 2

Conditions studied: Central Nervous System

In brief

This study is designed to evaluate the pharmacokinetics, efficacy, and safety of perampanel oral suspension on seizure frequency in pediatric participants maintained on one to three stable antiepileptic drugs

Key facts

Study ID: NCT01527006
Run by: Eisai Inc.
People needed: 63
Starts: 2012-01-01
Expected to finish: 2015-04-01
Last updated by the study team: 2016-07-12

Who can join

Age: 2 and older, up to 11. Sex: any. Healthy volunteers: not accepted.

Where it is running

Study site — Aurora, Colorado, United States
Study site — Washington D.C., District of Columbia, United States
Study site — Gulf Breeze, Florida, United States
Study site — Jacksonville, Florida, United States
Study site — Miami, Florida, United States
Study site — Orlando, Florida, United States
Study site — Tampa, Florida, United States
Study site — Augusta, Georgia, United States
Study site — Indianapolis, Indiana, United States
Study site — Lexington, Kentucky, United States
Study site — Shreveport, Louisiana, United States
Study site — Chesterfield, Missouri, United States
Study site — Columbia, Missouri, United States
Study site — Gibbsboro, New Jersey, United States
Study site — Buffalo, New York, United States
Study site — Akron, Ohio, United States
Study site — Cincinnati, Ohio, United States
Study site — Philadelphia, Pennsylvania, United States
Study site — Pittsburgh, Pennsylvania, United States
Study site — Memphis, Tennessee, United States
Study site — San Antonio, Texas, United States
Study site — Salt Lake City, Utah, United States
Study site — Richmond, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.